Adverum Biotechnologies, Inc. (0HA3.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:31PM BST
| Previous close | 1.1450 |
| Open | 1.1400 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.1400 - 1.2000 |
| 52-week range | 1.1400 - 1.2000 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 96.305M |
| Beta (5Y monthly) | 1.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5780 |
| Earnings date | 03 Aug 2022 - 08 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
How Much Of Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Do Institutions Own?
A look at the shareholders of Adverum Biotechnologies, Inc. ( NASDAQ:ADVM ) can tell us which group is most powerful...
- Zacks
Adverum (ADVM) Up on FDA Feedback for Gene Therapy Study
Adverum (ADVM) to submit IND amendment to the FDA by mid-2022 for starting a mid-stage study on its gene therapy candidate ADVM-022 for treating wet AMD eye disorder.
- Zacks
Should You Buy Adverum Biotechnologies (ADVM) Ahead of Earnings?
Adverum Biotechnologies (ADVM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
© 2022 Yahoo. All rights reserved.
